Citations

Showing 10 of 108081 citations.

Surgical Approach to the Operable Lung Cancer Patient
Pairolero, Peter C.

Mayo Clinic

The Journal of the Japanese Association for Chest Surgery | June 12, 2017 | Volume: 3 | Issue: 2 | Pages: 167-168

10.2995/jacsurg1987.3.2_167 Get It

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant Therapy
Suciu, Stefan , Eggermont, Alexander M.M. , Lorigan, Paul , Garbe, Claus , Cameron, David , Kotapati, Srividya , Chen, Tai‐Tsang , Wheatley, Keith , Ives, Natalie , Schaetzen, Gaetan de, Efendi, Achmad , Kirkwood, John M. , de Schaetzen, Gaetan, Buyse, Marc , Markovic, Svetomir N. , Cameron, David , Ives, Natalie

Mayo Clinic

JNCI: Journal of the National Cancer Institute | June 12, 2017 | Volume: 110 | Issue: 1 | Pages: 87-96

10.1093/jnci/djx133 | PMID 28922786 Get It

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
Link, Brian K. , Syrbu, Sergei , Thompson, Carrie A. , Farooq, Umar , Novak, Anne J. , Allmer, Cristine, Lunde, Julianne J. , Macon, William R. , Inwards, David J. , Johnston, Patrick B. , Micallef, Ivana N. , Nowakowski, Grzegorz S. , Ansell, Stephen M. , Weiner, George J. , Cerhan, James R. , Habermann, Thomas M. , Maurer, Matthew J. , Feldman, Andrew L. , Farooq, Umar , Slager, Susan L. , Kay, Neil E. , Witzig, Thomas E. , Link, Brian K , Weiner, George , Syrbu, Sergei

Mayo Clinic

International Journal of Epidemiology | June 12, 2017 | Volume: 46 | Issue: 6 | Pages: 1753-1754i

10.1093/ije/dyx119 | PMID 29025017 Get It

Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years
Hamidi, Oksana , Iñiguez‐Ariza, Nicole M. , Kittah, Nana Esi, Gruber, Lucinda , Bancos, Cristian, Tamhane, Shrikant , Iñiguez-Ariza, Nicole M, Young, William F. , Bancos, Irina , Hamidi, Oksana

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | June 12, 2017 | Volume: 102 | Issue: 9 | Pages: 3296-3305

10.1210/jc.2017-00992 | PMID 28605453 Get It

Abstract Context Malignant pheochromocytoma (PHEO) and paraganglioma (PGL) are rare and knowledge of the natural history is limited. Objective We aimed to describe baseline characteristics and outcomes of patients with malignant PHEO and PGL (PPGL) and to identify predictors of shorter survival. Design Retrospective review of patients with malignant PPGL evaluated from 1960 to 2016. Setting Referral center. Patients The group comprised 272 patients. Main Outcome Measures Baseline description, survival outcomes, and predictors of shorter survival were evaluated in patients with rapidly progressive (n = 29) and indolent disease (n = 188). Results Malignant PPGL was diagnosed at a median age of 39 years (range, 7 to 83 years), with synchronous metastases in 96 (35%) patients. In 176 (65%) patients, metastases developed at a median of 5.5 years (range, 0.3 to 53.4 years) from the initial diagnosis. Median follow-up was 8.2 years (range, 0.01 to 54.1 years). Median overall and disease-specific survivals were 24.6 and 33.7 years, respectively. Shorter survival correlated with male sex (P = 0.014), older age at the time of primary tumor (P = 0.0011), synchronous metastases (P < 0.0001), larger primary tumor size (P = 0.0039), elevated dopamine (P = 0.0195), and not undergoing primary tumor resection (P < 0.0001). There was no difference in the type of primary tumor or presence of SDHB mutation. Conclusions The clinical course of patients with malignant PPGL is remarkably variable. Rapid disease progression is associated with male sex, older age at diagnosis, synchronous metastases, larger tumor size, elevated dopamine, and not undergoing resection of primary tumor. An individualized approach to patients with metastatic PPGL is warranted.
Updates in venous thromboembolism management: evidence published in 2016
Bartlett, Matthew , Mauck, Karen F. , Bierle, Dennis M. , Saadiq, Rayya A. , Daniels, Paul R.

Mayo Clinic

Hospital Practice | June 12, 2017 | Volume: 45 | Issue: 3 | Pages: 65-69

10.1080/21548331.2017.1341801 | PMID 28604136 Get It

Continuing challenges and current issues in acute lymphoblastic leukemia
Kansagra, Ankit , Dahiya, Saurabh , Litzow, Mark R. , Litzow, Mark R. , Kansagra, Ankit

Mayo Clinic

Leukemia & Lymphoma | June 12, 2017 | Volume: 59 | Issue: 3 | Pages: 526-541

10.1080/10428194.2017.1335397 | PMID 28604239 Get It

Mild cognitive impairment as a risk factor for Parkinson's disease dementia
Hoogland, Jeroen , Boel, Judith A., Bie, Rob M.A. de , Geskus, Ronald B. , Schmand, Ben , Dalrymple‐Alford, John C. , Goldman, Jennifer G. , Tröster, Alexander I. , Burn, David J. , Geurtsen, Gert J. , Disease”, on behalf of the MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson, Rodríguez‐Oroz, María , Goldman, Jennifer G , Marras, Connie , Adler, Charles H. , Litvan, Irene , Disease”, on behalf of the MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson, Dalrymple-Alford, John C , de Bie, Rob M A , Geurtsen, Gert J

Mayo Clinic

Movement Disorders | June 12, 2017 | Volume: 32 | Issue: 7 | Pages: 1056-1065

10.1002/mds.27002 | PMID 28605056 Get It

ABSTRACT Background The International Parkinson and Movement Disorder Society criteria for mild cognitive impairment in PD were recently formulated. Objectives The aim of this international study was to evaluate the predictive validity of the comprehensive (level II) version of these criteria by assessment of their contribution to the hazard of PD dementia. Methods Individual patient data were selected from four separate studies on cognition in PD that provided information on demographics, motor examination, depression, neuropsychological examination suitable for application of level II criteria, and longitudinal follow‐up for conversion to dementia. Survival analysis evaluated the predictive value of level II criteria for cognitive decline toward dementia as expressed by the relative hazard of dementia. Results A total of 467 patients were included. The analyses showed a clear contribution of impairment according to level II mild cognitive impairment criteria, age, and severity of PD motor symptoms to the hazard of dementia. There was a trend of increasing hazard of dementia with declining neuropsychological performance. Conclusions This is the first large international study evaluating the predictive validity of level II mild cognitive impairment criteria for PD. The results showed a clear and unique contribution of classification according to level II criteria to the hazard of PD dementia. This finding supports their predictive validity and shows that they contribute important new information on the hazard of dementia, beyond known demographic and PD‐specific factors of influence. © 2017 International Parkinson and Movement Disorder Society
Generation and measurement of shear waves in micellar fluids using ultrasound-based methods
Amador, Carolina , Otilio, Bruno L., Kinnick, Randall R., Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | June 10, 2017 | Volume: 141 | Issue: 5_Supplement | Pages: 3887-3887

10.1121/1.4988714 Get It

Wormlike micellar fluids are viscoelastic and their mechanical properties have been evaluated with mechanically generated shear waves combined with optical detection as well as rheological testing. In this work, we describe the use of acoustic radiation force and ultrafast ultrasound imaging to generate shear waves and measure their propagation, respectively. This shear wave elastography (SWE) method has been used to measure the viscoelastic mechanical properties in tissue-mimicking phantoms and soft tissues. We tested micellar fluids made from cetrimonium bromide (CTAB) and sodium salicylate (NaSAL) with a 5:3 ratio with different concentrations (100, 200, 300, and 400 mM). We fit an extended Maxwell model to the rheological test data (0.001-15.91Hz) and used the model parameters to calculate the shear wave phase velocity in the range of the SWE data (100-500 Hz). The phase velocities calculated from the rheology testing compared well with the SWE results. The mean absolute error was less than 0.02 m/s for all the micellar fluids tested. The SWE method is nondestructive and can be used for characterization of the viscoelasticity of micellar fluids, which could be used as a model for biological tissues. [This work was supported in part by grant R01DK092255.]
Clinical trials evaluating potential therapies for light chain (AL) amyloidosis
Muchtar, Eli , Gertz, Morie A. , Muchtar, E

Mayo Clinic

Expert Opinion on Orphan Drugs | June 10, 2017 | Volume: 5 | Issue: 8 | Pages: 655-663

10.1080/21678707.2017.1341834 | PMID 34567849 Get It